Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04602013

Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma Clinical Trial

Official title:
A Prospective, Multi-center, Single-arm Clinical Study of Sintilimab Injection Combined With Concurrent Radiotherapy and Chemotherapy in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma (IMCORT)

Clinical Trial Summary

This study evaluated the effectiveness and safety of sintilimab combined with cCRT in patients with locally advanced ESCC.

Clinical Trial Description

This study evaluated the effectiveness and safety of sintilimab combined with cCRT in patients with locally advanced ESCC. The primary endpoint is PFS. Secondary points contains：ORR、OS、Qol. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04602013
Study type Interventional
Source Sichuan Cancer Hospital and Research Institute
Contact jiahua lyu, doctor
Phone 17713539529
Email winlttljh@163.com
Status Recruiting
Phase Phase 2
Start date October 11, 2020
Completion date May 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05743504 - Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients Phase 1/Phase 2
Recruiting NCT05520619 - Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) Phase 2
Not yet recruiting NCT05522894 - AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC Phase 2
Active, not recruiting NCT03914443 - A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma Phase 1
Not yet recruiting NCT06426797 - Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma Phase 2
Active, not recruiting NCT06342167 - Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma Phase 2
Recruiting NCT06187597 - Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) Phase 2
Recruiting NCT05130684 - Neo-NTP-CRT for Locally Advanced ESCC Phase 2
Not yet recruiting NCT04888403 - Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma Phase 2
Recruiting NCT03917966 - The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC Phase 2
Not yet recruiting NCT06356688 - A Clinical Study on the Efficacy and Safety of Paclitaxel Polymer Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Phase 2